Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Finckh

Showing results (181-190 of 225) with videos related to

Pageof 23
Sort By:
Frontiers in Immunology|October 31, 2022
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseasesCatherine E Raptis, Christoph T Berger, Adrian Ciurea, et al.
The Lancet. Rheumatology|December 21, 2020
Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional studyPhilippa M Wells, Adewale S Adebayo, Ruth C E Bowyer, et al.
Swiss Medical Weekly|April 3, 2023
Management of giant-cell arteritis in Switzerland: an online national surveyMichele Iudici, Andrea Katharina Hemmig, Mihaela Stegert, et al.
Rheumatology (Oxford, England)|October 21, 2019
Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three yearsBurkhard Möller, Daniel Aletaha, Michael Andor, et al.
Annals of the Rheumatic Diseases|June 17, 2016
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registersLouise K Mercer, Johan Askling, Pauline Raaschou, et al.
RMD Open|October 1, 2019
EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseasesAurélie Najm, Elena Nikiphorou, Marie Kostine, et al.
Seminars in Arthritis and Rheumatism|August 3, 2010
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registriesJeffrey R Curtis, Archana Jain, Johan Askling, et al.
Rheumatology (Oxford, England)|December 13, 2023
A potential role for chlamydial infection in rheumatoid arthritis developmentCeline Lamacchia, Romain Aymon, Brian C Hattel, et al.
The Journal of Rheumatology|February 17, 2018
Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss CohortMonika Hebeisen, Regula Neuenschwander, Almut Scherer, et al.
RMD Open|June 5, 2018
Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR projectMarian H van Beers-Tas, Marieke M Ter Wee, Lilian H van Tuyl, et al.
Pageof 23

Showing results (181-190 of 225) with videos related to

Sort By:
Pageof 23
Frontiers in Immunology|October 31, 2022
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseasesCatherine E Raptis, Christoph T Berger, Adrian Ciurea, et al.
The Lancet. Rheumatology|December 21, 2020
Associations between gut microbiota and genetic risk for rheumatoid arthritis in the absence of disease: a cross-sectional studyPhilippa M Wells, Adewale S Adebayo, Ruth C E Bowyer, et al.
Swiss Medical Weekly|April 3, 2023
Management of giant-cell arteritis in Switzerland: an online national surveyMichele Iudici, Andrea Katharina Hemmig, Mihaela Stegert, et al.
Rheumatology (Oxford, England)|October 21, 2019
Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three yearsBurkhard Möller, Daniel Aletaha, Michael Andor, et al.
Annals of the Rheumatic Diseases|June 17, 2016
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registersLouise K Mercer, Johan Askling, Pauline Raaschou, et al.
RMD Open|October 1, 2019
EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseasesAurélie Najm, Elena Nikiphorou, Marie Kostine, et al.
Seminars in Arthritis and Rheumatism|August 3, 2010
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registriesJeffrey R Curtis, Archana Jain, Johan Askling, et al.
Rheumatology (Oxford, England)|December 13, 2023
A potential role for chlamydial infection in rheumatoid arthritis developmentCeline Lamacchia, Romain Aymon, Brian C Hattel, et al.
The Journal of Rheumatology|February 17, 2018
Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss CohortMonika Hebeisen, Regula Neuenschwander, Almut Scherer, et al.
RMD Open|June 5, 2018
Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR projectMarian H van Beers-Tas, Marieke M Ter Wee, Lilian H van Tuyl, et al.
Pageof 23